RIL
TEVA icon

Rothschild Investment LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Rothschild Investment LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.8K Buy
2,504
+52
+2% +$1.73K ﹤0.01% 1112
2026
Q1 		$73.9K Sell
2,452
-104
-4% -$3.35K ﹤0.01% 1006
2025
Q4 		$79.8K Sell
2,556
-182
-7% -$4.48K ﹤0.01% 879
2025
Q3 		$55.3K Buy
2,738
+1,348
+97% +$23.7K ﹤0.01% 961
2025
Q2 		$23.3K Buy
1,390
+88
+7% +$1.42K ﹤0.01% 987
2025
Q1 		$20K Sell
1,302
-234
-15% -$4.18K ﹤0.01% 999
2024
Q4 		$33.9K Sell
1,536
-820
-35% -$14.9K ﹤0.01% 872
2024
Q3 		$42.5K Buy
2,356
+1,994
+551% +$34.9K ﹤0.01% 820
2024
Q2 		$5.88K Buy
362
+151
+72% +$2.33K ﹤0.01% 1179
2024
Q1 		$2.98K Buy
211
+24
+13% +$303 ﹤0.01% 1182
2023
Q4 		$1.95K Buy
+187
New +$1.75K ﹤0.01% 1148
2017
Q4 		– Sell
-16,577
Closed -$292K – 419
2017
Q3 		$292K Sell
16,577
-7,650
-32% -$172K 0.03% 345
2017
Q2 		$805K Buy
24,227
+15,357
+173% +$475K 0.09% 222
2017
Q1 		$285K Buy
8,870
+166
+2% +$5.67K 0.03% 358
2016
Q4 		$316K Sell
8,704
-8,689
-50% -$347K 0.04% 333
2016
Q3 		$800K Buy
17,393
+263
+2% +$13.7K 0.1% 199
2016
Q2 		$860K Sell
17,130
-500
-3% -$26.6K 0.11% 189
2016
Q1 		$943K Hold
17,630
– – 0.12% 182
2015
Q4 		$1.16M Hold
17,630
– – 0.15% 158
2015
Q3 		$995K Hold
17,630
– – 0.13% 177
2015
Q2 		$1.04M Buy
17,630
+140
+0.8% +$8.64K 0.12% 191
2015
Q1 		$1.09M Hold
17,490
– – 0.13% 175
2014
Q4 		$1.01M Buy
17,490
+6,689
+62% +$373K 0.12% 179
2014
Q3 		$581K Buy
10,801
+111
+1% +$5.88K 0.07% 272
2014
Q2 		$560K Hold
10,690
– – 0.07% 247
2014
Q1 		$565K Sell
10,690
-850
-7% -$39.3K 0.08% 248
2013
Q4 		$463K Sell
11,540
-700
-6% -$27.6K 0.06% 279
2013
Q3 		$462K Hold
12,240
– – 0.07% 262
2013
Q2 		$480K Buy
+12,240
New +$477K 0.08% 235

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rothschild Investment LLC's TEVA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Teva Pharmaceuticals (TEVA) stake by 2.1% in Q2 2026, buying an estimated $1.73K and bringing the position to 2,504 shares worth $84.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Rothschild Investment LLC first reported a position in TEVA in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.16M in Q4 2015. 528 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Rothschild Investment LLC held 2,504 shares of Teva Pharmaceuticals worth $84.8K as of Q2 2026.
  • Rothschild Investment LLC bought 52 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.73K.
  • Teva Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1112 holding.
  • Rothschild Investment LLC first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 29 quarters since.
  • Rothschild Investment LLC's Teva Pharmaceuticals position peaked at $1.16M in Q4 2015.
  • 528 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.